Adagio Medical Holdings, Inc.

ADGM Nasdaq SEC CIK 2006986
Follow Adagio Medical Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $0
EPS, diluted $2.40 +112.2% vs same quarter last year
Operating cash flow −$4.6M −53.2% vs same quarter last year
Operating income −$4.4M +23.6% vs same quarter last year
Revenue by quarter
$0
$0
$0
$0
$0
$0
$0
Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing